Add Lombard Med.tec to quick picks

Lombard Med.tec Share Price (LMT)



Share Price Information for Lombard Med.tec (LMT)


Share Price: 190.00Bid: 188.00Ask: 192.00Change: 0.00 (0.00%)No Movement on Lombard Med.tec
Spread: 4.00Spread as %: 2.13%Open: 195.00High: 192.12Low: 188.80Yesterday’s Close: 190.00

LOMBARD MEDICAL TECHNOLOGIES PLC ORD 20P

Lombard Med.tec is part of the Health Care Equipment & Services sector




Intraday Lombard Med.tec Share Chart


Intraday Lombard Med.tec Share Price Chart


Share Price SpacerPrice
190.00

Share Price SpacerBid
188.00

Share Price SpacerAsk
192.00

Share Price SpacerChange
0.00%No Movement on Lombard Med.tec0.00

Share Price SpacerVolume
4,421

Share Price SpacerOpen
195.00

Share Price SpacerHigh
192.12

Share Price SpacerLow
188.80

Share Price SpacerClose
190.00

Share Price SpacerCurrency
GBX

3 Month Lombard Med.tec Share Graph


3 Month Lombard Med.tec Share Price Graph


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 30.20m £57.38m 200

52 Week High 245.00 52 Week High Date 15-FEB-2013
52 Week Low 100.00 52 Week Low Date 10-OCT-2012

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
9 4,421 0 -4.623 -41.10 0.00 0.00


London South East Users info for Lombard Med.tec


Users who watch LMT also watch:

Users who hold LMT also hold: Taylor Wimpey, Lloyds Grp., Royal Bank Scot, Victoria Oil


Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

17-May-13
13:52:09
188.80
521
Sell* 
188.00
192.00
983.65
Trade Type:
Ordinary

17-May-13
13:50:17
190.00
500
Sell* 
190.00
195.00
950.00
Trade Type:
Ordinary

17-May-13
13:50:15
190.00
200
Sell* 
190.00
195.00
380.00
Trade Type:
Ordinary


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Lombard Med.tec trades >>

Directors Deals for Lombard Med.tec (LMT)
Trade DateActionNotifierPriceCurrencyAmountHolding
22-Mar-13Buy
Trade Notifier Information for Lombard Medical Technologies
John Rush held the position of Non-Executive Chairman at Lombard Medical Technologies at the time of this trade.
 John Rush
04,00012142
22-Mar-13Buy
Trade Notifier Information for Lombard Medical Technologies
Peter Phillips held the position of Chief Technology Officer at Lombard Medical Technologies at the time of this trade.
 Peter Phillips
06,00012214
22-Mar-13Buy
Trade Notifier Information for Lombard Medical Technologies
Simon Hubbert held the position of CEO at Lombard Medical Technologies at the time of this trade.
 Simon Hubbert
04,0007142
View more Lombard Med.tec directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
6 Mar '13
TC101
Observation
206.50
Hold

Lots of sells recently! Either profit taking or someone knows something we dont. Surprising as LMT have approval now. Need to be quick and start getting thoses sales teams rolling in the orders! Strike whilst the iron is hot! Unless takeover is on a few peoples mind. Need to watch this closely!
27 Feb '13
TC101
Edison Investment Research
215.50
Hold

Edison Investment Research values the shares at £3.46 since LMT got approval. I hope they are right!
25 Feb '13
TC101
Jange
213.00
Hold

Jange - Its great that you can cut and paste the RNS's .....but what are your opinions on the stock?? Well.....take over could happen so i think we need to keep an eye on that! Just need to see how they are going to penetrate the US marketing since approval was given!
24 Feb '13
jange
LMT
212.50
No Opinion

Business description Lombard Medical Technologies is a UK medical technology firm principally focused on the development and commercialisation of the Aorfix stent graft system which is approved in Europe and the US for the endovascular (minimally invasive) repair of abdominal aortic aneurysm (AAA).
24 Feb '13
jange
LMT
212.50
No Opinion

140p. Valuation: Increased to £104.7m from £97.7m We have increased our DCF valuation of Lombard from £97.7m to £104.7m or 346p/share (with a pro forma 30.3m shares in issue), having rolled forward our DCF by half a year. Our valuation previously included the expected US approval of Aorfix at the end of 2012. US launch is now expected in the second half of 2013. We will review our forecasts after the company’s full year results in March.
24 Feb '13
jange
LMT
212.50
No Opinion

Funded to go The fundraising will provide funds to support the US launch, gear up production and develop a next generation lower profile version of Aorfix. Lombard could also repay its £3m convertible loan with Invesco (owns 39% of shares) before 1 July 2013. Thereafter the loan is convertible to equity at the strike price of 140p.

Share prices shown are taken at time of message posting.
NEWThread ViewThread View
View more share chat for Lombard Med.tec (LMT) >>
Please Login or Register to post messages

Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs




Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.